Shuttle Pharmaceuticals Holdings reported net income of -$2.20M for the quarter ended Mar 2026. This income statement covers 19 quarters of results from Sep 2021 through Mar 2026, standardized by Business Quant from the company’s SEC filings.
| Income Statement | Sep2021 | Dec2021 | Mar2022 | Jun2022 | Sep2022 | Dec2022 | Mar2023 | Jun2023 | Sep2023 | Dec2023 | Mar2024 | Jun2024 | Sep2024 | Dec2024 | Mar2025 | Jun2025 | Sep2025 | Dec2025 | Mar2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Shares Outstanding (Entity)Shares Outstanding (Entity.) | 0.00M | 0.00M | 0.00M | 0.00M | 0.01M | 0.01M | 0.01M | 0.01M | 0.01M | 0.01M | 0.01M | 0.01M | 0.01M | 0.01M | 0.04M | 0.11M | 0.22M | 0.16M | 0.56M |
| Operating items | |||||||||||||||||||
| Research & DevelopmentR&D | 0.19M | 0.44M | 0.30M | 0.08M | 0.67M | -0.00M | 0.92M | 0.84M | 1.05M | 0.71M | 0.60M | 0.65M | 1.40M | 0.99M | 1.57M | 1.03M | 0.94M | 0.51M | 0.27M |
| Selling, General & AdministrativeSG&A | 0.01M | 0.02M | 0.01M | 0.01M | 0.08M | 0.37M | 0.26M | 0.21M | 0.27M | 0.32M | 0.32M | 0.31M | 0.33M | 0.43M | 0.60M | 2.35M | 0.89M | 1.84M | 1.16M |
| Other Operating ExpensesOther Opex | 0.05M | 0.53M | 0.33M | 0.26M | 0.33M | 0.16M | 0.37M | 0.42M | 0.29M | 0.26M | 0.46M | 0.53M | 1.32M | 0.36M | 0.78M | 0.54M | 0.44M | 1.14M | 0.79M |
| Operating ExpensesOpex | 0.24M | 0.99M | 0.64M | 0.35M | 0.82M | 0.53M | 1.54M | 1.47M | 1.60M | 1.28M | 1.38M | 1.48M | 3.05M | 1.78M | 2.95M | 3.91M | 2.27M | 3.50M | 2.22M |
| Operating IncomeOp. Inc | -0.24M | -0.99M | -0.64M | -0.35M | -0.82M | -0.53M | -1.54M | -1.47M | -1.60M | -1.28M | -1.38M | -1.48M | -3.05M | -1.78M | -2.95M | -3.91M | -2.27M | -2.79M | -2.22M |
| EBIT | -0.24M | -0.99M | -0.64M | -0.35M | -0.82M | -0.53M | -1.54M | -1.47M | -1.60M | -1.28M | -1.38M | -1.48M | -3.05M | -1.78M | -2.95M | -3.91M | -2.27M | -2.79M | -2.22M |
| Non-operating items | |||||||||||||||||||
| Non Operating Interest Expenses | 0.01M | 0.02M | 0.15M | 0.17M | 0.60M | -0.00M | 0.46M | 0.55M | 0.62M | 0.17M | 0.45M | 0.43M | 0.27M | -1.19M | 0.01M | 0.02M | 0.02M | -0.04M | 0.01M |
| Non Operating Investment Income | 0.04M | -0.03M | 0.01M | 0.05M | -706.00 | -0.03M | -0.04M | ||||||||||||
| Interest & Investment IncomeInt & Inv Inc | 0.02M | 0.02M | 0.02M | 0.02M | 0.02M | 0.01M | 0.00M | 3.00 | 81.00 | 486.00 | 523.00 | 209.00 | |||||||
| Other Non Operating IncomeOther Non Op Inc. | 0.06M | 0.04M | -0.06M | 0.33M | -0.52M | 1.24M | 0.43M | 0.44M | 0.10M | 0.20M | -0.14M | 0.29M | 0.22M | 0.00M | 0.01M | 0.00M | 0.33M | 0.08M | |
| Non Operating IncomeNon Op. Inc. | 0.03M | 0.53M | -0.04M | -0.24M | -0.18M | -2.19M | 0.57M | -0.72M | -0.19M | -0.36M | -0.35M | -0.55M | -0.73M | 0.18M | -0.10M | 0.20M | -0.08M | 0.17M | 0.06M |
| Net income details | |||||||||||||||||||
| EBT | -0.22M | -0.46M | -0.68M | -0.52M | -1.00M | -2.72M | -0.98M | -2.00M | -1.78M | -2.20M | -1.81M | -1.90M | -3.32M | -0.59M | -2.96M | -3.93M | -2.28M | -2.75M | -2.23M |
| Profit After TaxPAT | -0.22M | -0.46M | -0.68M | -0.60M | -1.00M | -0.75M | -0.98M | -2.18M | -1.79M | -1.64M | -1.73M | -2.03M | -3.78M | -1.60M | -3.05M | -3.71M | -2.35M | -2.61M | -2.20M |
| Income from Continuing OperationsIncome (Continuing) | -0.22M | -0.46M | -0.68M | -0.52M | -1.00M | -2.72M | -0.98M | -2.00M | -1.78M | -2.20M | -1.81M | -1.90M | -3.32M | -0.59M | -2.96M | -3.93M | -2.28M | -2.75M | -2.23M |
| Consolidated Net IncomeConsol Net Inc. | -0.22M | -0.46M | -0.68M | -0.52M | -1.00M | -2.72M | -0.98M | -2.00M | -1.78M | -2.20M | -1.81M | -1.90M | -3.32M | -0.59M | -2.96M | -3.93M | -2.28M | -2.75M | -2.23M |
| Income towards Parent CompanyParent Net Inc | -0.22M | -0.46M | -0.68M | -0.52M | -1.00M | -2.72M | -0.98M | -2.00M | -1.78M | -2.20M | -1.81M | -1.90M | -3.32M | -0.59M | -2.96M | -3.93M | -2.28M | -2.75M | -2.23M |
| Preferred Dividend PaymentsPref Dividends | 0.03M | 0.03M | 0.03M | 0.03M | 0.02M | 0.37M | |||||||||||||
| Net Income towards Common StockholdersNet Income | -0.24M | -0.48M | -0.71M | -0.62M | -1.02M | -4.40M | -0.98M | -2.18M | -1.79M | -1.64M | -1.81M | -1.90M | -3.32M | -0.59M | -2.96M | -3.93M | -2.28M | -2.75M | -2.23M |
| Additional items | |||||||||||||||||||
| EPS (Basic) | -52.24 | -104.24 | -151.98 | -133.82 | -200.29 | -849.80 | -143.02 | -306.32 | -227.74 | -219.91 | -218.31 | -225.55 | -348.07 | -51.14 | -73.58 | -34.90 | -10.23 | -16.81 | -4.43 |
| EPS (Diluted) | -133.82 | -218.62 | -849.80 | -143.02 | -306.32 | -227.51 | -219.91 | -218.31 | -225.55 | -348.07 | -50.83 | -73.58 | -34.90 | -10.23 | -16.81 | -4.43 | |||
| Shares Outstanding | 0.00M | 0.00M | 0.00M | 0.00M | 0.01M | 0.01M | 0.01M | 0.01M | 0.01M | 0.01M | 0.01M | 0.01M | 0.01M | 0.01M | 0.04M | 0.11M | 0.22M | 0.16M | 0.50M |
| Shares Outstanding (Diluted)Shares Outstanding (Dil.) | 0.00M | 0.00M | 0.01M | 0.01M | 0.01M | 0.01M | 0.01M | 0.01M | 0.01M | 0.01M | 0.01M | 0.04M | 0.11M | 0.22M | 0.16M | 0.50M | |||
| EBITDA | -0.24M | -0.99M | -0.64M | -0.35M | -0.82M | -0.53M | -1.54M | -1.47M | -1.60M | -1.28M | -1.38M | -1.48M | -3.05M | -1.78M | -2.95M | -3.91M | -2.27M | -2.79M | -2.22M |
| Interest ExpensesInt Expense | 0.01M | 0.02M | 0.15M | 0.17M | 0.60M | -0.00M | 0.46M | 0.55M | 0.62M | 0.17M | 0.45M | 0.43M | 0.27M | -1.19M | 0.01M | 0.02M | 0.02M | -0.04M | 0.01M |